NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

globenewswire

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program – NEWSnet – News… as it used to be

More Press Releases

May 4, 2026

Enabled Talent Launches Fellowship for Persons with Disabilities Focused on Employment and Self-Employment

May 4, 2026

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

May 4, 2026

Great Elm Capital Corp. Announces First Quarter 2026 Financial Results

May 4, 2026

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

Enabled Talent Launches Fellowship for Persons with Disabilities Focused on Employment and Self-Employment

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Great Elm Capital Corp. Announces First Quarter 2026 Financial Results

Silvaco Announces Participation at Upcoming Investor Conferences